<i>TP53</i> and Decitabine in Acute Myeloid Leukemia and Myelodysplastic SyndromesJohn S. Welch, Timothy J. Ley, Allegra A. Petti et al.|New England Journal of Medicine|2016Cited by 783
Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in OncologyMargaret O’Donnell, Ndiya Ogba, William Blum et al.|Journal of the National Comprehensive Cancer Network|2017Cited by 655
Severe Cytokine-Release Syndrome after T Cell–Replete Peripheral Blood Haploidentical Donor Transplantation Is Associated with Poor Survival and Anti–IL-6 Therapy Is Safe and Well ToleratedRamzi Abboud, Rizwan Romee, Jesse Keller et al.|Biology of Blood and Marrow Transplantation|2016Cited by 164
Impact of a 40-Gene Targeted Panel Test on Physician Decision Making for Patients With Acute Myeloid LeukemiaErica K. Barnell, Obi L. Griffith, Kenneth F. Newcomer et al.|JCO Precision Oncology|2021Cited by 9